Barbagallo Federica, Cannarella Rossella, Bertelli Matteo, Crafa Andrea, La Vignera Sandro, Condorelli Rosita A, Calogero Aldo E
Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
MAGI EUREGIO, 39100 Bolzano, Italy.
Medicina (Kaunas). 2021 Oct 21;57(11):1142. doi: 10.3390/medicina57111142.
: Androgen insensitivity syndrome (AIS), an X-linked recessive disorder of sex development (DSD), is caused by variants of the androgen receptor () gene, mapping in the long arm of the X chromosome, which cause a complete loss of function of the receptor. : We report a patient diagnosed with complete AIS (CAIS) at birth due to swelling in the bilateral inguinal region. Transabdominal ultrasound revealed the absence of the uterus and ovaries and the presence of bilateral testes in the inguinal region. The karyotype was 46,XY. She underwent bilateral orchiectomy at 9 months and was given estrogen substitutive therapy at the age of 11 years. Genetic analysis of the AR gene variants was requested when, at the age of 20, the patient came to our observation. : The genetic testing was performed by next-generation sequence (NGS) analysis. : The genetic analysis showed the presence of the c.2242T>A, p.(Phe748Ile) variant in the gene. To the best of our knowledge, this variant has not been published so far. Furthermore, the patient has a heterozygous c.317A>G, p.(Gln106Arg) variation of the gonadotropin-releasing hormone receptor () gene, a heterozygous c.2273G>A, p.Arg758His variation of the chromodomain helicase DNA binding protein () gene, and compound heterozygous c.875A>G, p.Tyr292Cys, and c.8023A>G, p.Ile2675Val variations of the Dynein Axonemal Heavy Chain () gene. : The case herein reported underlines the importance of an accurate genetic analysis that has to include karyotype and gene variant analysis. This is useful to confirm a clinical diagnosis and establish the proper management of patients with CAIS. Numerous variants of the gene have not yet been identified. Moreover, several pitfalls are still present in the management of these patients. More studies are needed to answer unresolved questions, and common protocols are required for the clinical follow-up of patients with CAIS.
雄激素不敏感综合征(AIS)是一种X连锁隐性性发育障碍(DSD),由雄激素受体(AR)基因的变异引起,该基因位于X染色体长臂,会导致受体功能完全丧失。我们报告一名出生时因双侧腹股沟区肿胀被诊断为完全性AIS(CAIS)的患者。经腹超声显示子宫和卵巢缺如,腹股沟区存在双侧睾丸。核型为46,XY。她在9个月时接受了双侧睾丸切除术,并在11岁时接受了雌激素替代治疗。患者20岁前来就诊时,要求对AR基因变异进行基因分析。基因检测通过下一代测序(NGS)分析进行。基因分析显示AR基因存在c.2242T>A,p.(Phe748Ile)变异。据我们所知,该变异迄今尚未见报道。此外,患者促性腺激素释放激素受体(GnRHR)基因存在杂合性c.317A>G,p.(Gln106Arg)变异,染色质结构域解旋酶DNA结合蛋白(CHD1)基因存在杂合性c.2273G>A,p.Arg758His变异,动力蛋白轴丝重链(DNAH)基因存在复合杂合性c.875A>G,p.Tyr292Cys和c.8023A>G,p.Ile2675Val变异。本文报道的病例强调了准确的基因分析的重要性,基因分析必须包括核型和AR基因变异分析。这有助于确诊临床诊断并确定CAIS患者的适当管理。AR基因的许多变异尚未被鉴定。此外,这些患者的管理中仍存在一些陷阱。需要更多研究来回答未解决问题,并且需要通用方案用于CAIS患者的临床随访。